Latest stories

  • Clinical Trials Announced for New Lyme Disease Vaccine

    Clinical Trials Announced for New Lyme Disease Vaccine

    Clinical Trials Announced for New Lyme Disease Vaccine Valneva, a French company focused on developing innovative life-saving vaccines, announced in mid-December that its vaccine candidate VLA15 against Lyme disease has received US Food and Drug Administration (FDA) and European Union Clinical Trial Application (CTA) approval to conduct a Phase I trial in 180 adults in […] More

  • 3D Ultrasound

    FDA Warns Against Keepsake Ultrasounds

    Once only a tool that could provide doctors with vital information about the condition of an unborn baby, ultrasounds have entered the realm of commercialism with facilities around the United States offering 3D fetal images of unborn children as keepsakes. But neither fetal ultrasound imaging nor Doppler fetal ultrasound heartbeat monitors are intended for over-the-counter […] More

  • FDA Approves New Meningococcal Disease Vaccine

    FDA Approves Second Vaccine to Prevent Serogroup B Meningococcal Disease

    The Food and Drug Administration (FDA) has approved a second vaccine for individuals between the ages of 10 and 25 years old to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroup B: Bexsero. Meningococcal disease refers to any illness caused by the bacteria Neisseria meningitidis. Meningococcus bacteria spread through the exchange of respiratory and […] More

  • The Problem with the VAERS Database

    The Problem with the VAERS Database

    As my readers know, I am an ardent supporter of vaccines and vaccination. This past weekend, I saw a post being shared on Facebook by a number of pages. The post entitled “ZERO U.S. Measles Deaths in 10 Years, but Over 100 Measles Vaccine Deaths Reported” argues against the value of vaccines with two statistics, […] More